C. Voltz

SR141716, a central cannabinoid (CB1) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats

Caroline Cohen, Ghislaine Perrault, C. Voltz et al. · Behavioural Pharmacology · 2002 · 392 citations

Neuropsychology, Receptor Antagonist, Dopamine-releasing Effects +20

SSR180711, a Novel Selective α7 Nicotinic Receptor Partial Agonist: (II) Efficacy in Experimental Models Predictive of Activity Against Cognitive Symptoms of Schizophrenia

Philippe Pichat, Olivier Bergis, Jean-Paul Terranova et al. · Neuropsychopharmacology · 2006 · 237 citations · Full text

Psychiatry, Psychotic Disorder, Medicine +10

SSR591813, a Novel Selective and Partial α4β2 Nicotinic Receptor Agonist with Potential as an Aid to Smoking Cessation

Caroline Cohen, Olivier Bergis, Francesco Galli et al. · Journal of Pharmacology and Experimental Therapeutics · 2003 · 114 citations · Full text

Selective Release of Spermine and Spermidine from the Rat Striatum by N‐Methyl‐<scp>d</scp>‐Aspartate Receptor Activation In Vivo

Dominique Fage, C. Voltz, B. Scatton et al. · Journal of Neurochemistry · 1992 · 88 citations

Dialysis Cannula, Selective Release, Medicine +14

The effects ofN-methyl-d-aspartate and kainate lesions of the rat striatum on striatal ornithine decar☐ylase activity and polyamine levels

Anna Porcella, Christopher Carter, Dominique Fage et al. · Brain Research · 1991 · 42 citations

Polyamine Levels, Molecular Neuroscience, Medicine +9